Interview with Founder and CEO Peter Luo, Adagene

episode

China of Tomorrow not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026 · EyeCode Media

Essentials: How to Assess & Improve All Aspects of Your Fitness | Dr. Andy Galpin 35 min · 17 Sep 2026 · Huberman Lab

#502 – Psychiatry, Insane Asylums, Mental Illness, ECT, Lobotomies, Freud & Jung 3h 43m · 17 Sep 2026 · Lex Fridman Podcast

September 16, 2026 PC - Sep 16, 2026 1h 50m · 16 Sep 2026 · Fairfax County Planning Commission

Planning Commision 09/16/2026 - Sep 16, 2026 56 min · 16 Sep 2026 · Prince William County Planning Commission

Western Loudoun Rural Uses and Standards PCZOC Ad Hoc Meeting 2 - Sep 16, 2026 4h 45m · 16 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Report any issue

Source

Recorded11 May 2022

Publisheranchor.fm ↗

Handlerec:5912496

Show notes

On this week’s episode of China of Tomorrow, Liqian Ren is joined by Co-founder and Chief Executive Officer Peter Luo, PhD at Adagene, a biotech company that is applying its AI powered technology platform to develop new antibody treatments for cancer. During the episode, Liqian and Dr. Luo cover the latest developments in the pharmaceutical industry affecting productivity rates in research and development, and their established practices when conducting business globally specifically, in China and more.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in